MedTrace Logo

Statins in Frail Older Patients with Ischemic Stroke or Transient Ischemic Attack - the Prospective Cohort Study

NCT06785740 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2025-01-21

No results posted yet for this study

Summary

Two Dutch guidelines (Stroke and Cardiovascular Risk Management) provide conflicting advice on optimal statin treatment in older patients. In the SAFEST-cohort, the investigators will assess the impact of continuing versus discontinuing a statin in frail individuals aged 70 and above with a recent ischemic stroke or transient ischemic attack (TIA) on their health-related quality of life and MACE free survival during a two-year follow-up period.

Conditions

Interventions

DRUG

Statin

Statin use

Sponsors & Collaborators

  • VU University of Amsterdam

    collaborator OTHER

  • Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

    lead OTHER

Principal Investigators

  • Renske van den Berg-Vos, Prof. dr. · Amsterdam UMC, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

  • Nathalie van der Velde, Prof. dr. · Amsterdam UMC, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

Eligibility

Min Age
70 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-01
Primary Completion
2029-09-30
Completion
2029-09-30

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06785740 on ClinicalTrials.gov